Literature DB >> 31780633

circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia.

Shweta Pradip Jadhav1, Nishi Kumari1,2, Larry Ng1,2, Pei Fang Tan3, Nicole Shu Ling Yeo-Teh1,4, Yufen Goh1, Wee Nih Fam1, Jia Qi Tng1, Johann Shane Tian1,2, Bryan T H Koh5, Chan Ming Chun5, Wilson Wang6, Wee Joo Chng1,7, Melissa Jane Fullwood1,8,9, Ernesto Guccione9,10, Neerja Karnani3,2, Daniel G Tenen1,11, Sudhakar Jha1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31780633      PMCID： PMC7327662          DOI： 10.3324/haematol.2019.225961

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  A 360° view of circular RNAs: From biogenesis to functions.

Authors:  Jeremy E Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-14       Impact factor: 9.957

2.  The long non-coding RNA lncFOXO1 suppresses growth of human breast cancer cells through association with BAP1.

Authors:  Jie Xi; Jing Feng; Qian Li; Xia Li; Saitian Zeng
Journal:  Int J Oncol       Date:  2017-03-24       Impact factor: 5.650

3.  Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.

Authors:  Jlenia Guarnerio; Marco Bezzi; Jong Cheol Jeong; Stella V Paffenholz; Kelsey Berry; Matteo M Naldini; Francesco Lo-Coco; Yvonne Tay; Andrew H Beck; Pier Paolo Pandolfi
Journal:  Cell       Date:  2016-03-31       Impact factor: 41.582

4.  Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types.

Authors:  Julia Salzman; Charles Gawad; Peter Lincoln Wang; Norman Lacayo; Patrick O Brown
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

5.  Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.

Authors:  Anand Balasubramani; Antti Larjo; Jed A Bassein; Xing Chang; Ryan B Hastie; Susan M Togher; Harri Lähdesmäki; Anjana Rao
Journal:  Nat Commun       Date:  2015-06-22       Impact factor: 14.919

6.  Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells.

Authors:  Winston Koh; Veronica Gonzalez; Sivaraman Natarajan; Robert Carter; Patrick O Brown; Charles Gawad
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

7.  ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

Authors:  Omar Abdel-Wahab; Mazhar Adli; Lindsay M LaFave; Jie Gao; Todd Hricik; Alan H Shih; Suveg Pandey; Jay P Patel; Young Rock Chung; Richard Koche; Fabiana Perna; Xinyang Zhao; Jordan E Taylor; Christopher Y Park; Martin Carroll; Ari Melnick; Stephen D Nimer; Jacob D Jaffe; Iannis Aifantis; Bradley E Bernstein; Ross L Levine
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

Review 8.  Circular RNAs in cancer: opportunities and challenges in the field.

Authors:  L S Kristensen; T B Hansen; M T Venø; J Kjems
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

9.  Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.

Authors:  Reina Nagase; Daichi Inoue; Alessandro Pastore; Takeshi Fujino; Hsin-An Hou; Norimasa Yamasaki; Susumu Goyama; Makoto Saika; Akinori Kanai; Yasuyuki Sera; Sayuri Horikawa; Yasunori Ota; Shuhei Asada; Yasutaka Hayashi; Kimihito Cojin Kawabata; Reina Takeda; Hwei-Fang Tien; Hiroaki Honda; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Exp Med       Date:  2018-04-11       Impact factor: 14.307

10.  Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.

Authors:  Shuhei Asada; Susumu Goyama; Daichi Inoue; Shiori Shikata; Reina Takeda; Tsuyoshi Fukushima; Taishi Yonezawa; Takeshi Fujino; Yasutaka Hayashi; Kimihito Cojin Kawabata; Tomofusa Fukuyama; Yosuke Tanaka; Akihiko Yokoyama; Satoshi Yamazaki; Hiroko Kozuka-Hata; Masaaki Oyama; Shinya Kojima; Masahito Kawazu; Hiroyuki Mano; Toshio Kitamura
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919
View more
  5 in total

Review 1.  Roles of circRNAs in hematological malignancies.

Authors:  Fahua Deng; Chengsi Zhang; Tingting Lu; Ezhong Joshua Liao; Hai Huang; Sixi Wei
Journal:  Biomark Res       Date:  2022-07-15

2.  CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs.

Authors:  Xiaoling Wang; Peng Jin; Yi Zhang; Kankan Wang
Journal:  Cell Death Dis       Date:  2021-03-19       Impact factor: 8.469

3.  A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia.

Authors:  Leilei Lin; Yu Wang; Sicheng Bian; Lili Sun; Zhibo Guo; Desheng Kong; Linlin Zhao; Dan Guo; Qi Li; Min Wu; Yuhuang Wang; Yuying Wang; Yinghua Li
Journal:  J Transl Med       Date:  2021-03-23       Impact factor: 5.531

Review 4.  Circular RNAs in stem cells: from basic research to clinical implications.

Authors:  Hui-Juan Lu; Juan Li; Guodong Yang; Cun-Jian Yi; Daping Zhang; Fenggang Yu; Zhaowu Ma
Journal:  Biosci Rep       Date:  2022-01-28       Impact factor: 3.840

5.  CircASXL1 knockdown represses the progression of colorectal cancer by downregulating GRIK3 expression by sponging miR-1205.

Authors:  Guojiu Fang; Yibin Wu; Xueli Zhang
Journal:  World J Surg Oncol       Date:  2021-06-14       Impact factor: 2.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.